Efficacy of metoprolol and sotalol in the prevention of recurrences of sustained ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillator

被引:40
作者
Kettering, K
Mewis, C
Dörnbergdr, V
Vonthein, R
Bosch, RF
Kühlkamp, V
机构
[1] Univ Tubingen, Dept Cardiol, D-72076 Tubingen, Germany
[2] Univ Tubingen, Dept Biostat, D-72076 Tubingen, Germany
来源
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY | 2002年 / 25卷 / 11期
关键词
defibrillators; implantable; tachycardia; ventricular; ventricular fibrillation; sotalol; metoprolol;
D O I
10.1046/j.1460-9592.2002.01571.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ICDs provide protection against sudden cardiac death in patients with life-threatening ventricular arrhythmias. Nevertheless, most ICD recipients receive adjunctive antiarrhythmic drug therapy to reduce the number of recurrent episodes and ICD discharges. The aim of the study was to compare the efficacy of metoprolol and d,l-sotalol in preventing VT/VF recurrences in patients with an ICD in a prospective, randomized trial. One hundred patients (83 men, 17 women; mean age 59 years, SD +/- 11 years) were randomized to receive metoprolol or sotalol after implantation of an ICD. There were no significant differences between the two groups with regard to age, sex, underlying cardiac disease, left ventricular ejection fraction, NYHA class assessment and clinical arrhythmia. The median follow-up was 728 days (25th percentile: 530 days, 75th percentile: 943 days) in the metoprolol group and 727 days (25th percentile: 472 days, 75th percentile: 1,223 days) in the sotalol group (P = 0.52). Thirty-three patients treated with metoprolol and 30 patients receiving sotalol had at least one episode during the follow-up. Event-free survival curves were generated for the two treatment arms using the Kaplan-Meier method and showed no significant difference (P 0.68). Eight patients treated with metoprolol and six patients treated with sotalol died during follow-up. Total mortality was not significantly different between the two study groups (P = 0.43). Metoprolol is as efficacious as sotalol in preventing VT/VF recurrences in patients with an ICD.
引用
收藏
页码:1571 / 1576
页数:6
相关论文
共 18 条
[1]  
[Anonymous], 1989, NEW ENGL J MED, V321, P406
[2]   METOPROLOL VERSUS SOTALOL IN THE TREATMENT OF SUSTAINED VENTRICULAR-TACHYCARDIA [J].
ANTZ, M ;
CAPPATO, R ;
KUCK, KH .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1995, 26 (04) :627-635
[3]   Canadian implantable defibrillator study (CIDS) - A randomized trial of the implantable cardioverter defibrillator against amiodarone [J].
Connolly, SJ ;
Gent, M ;
Roberts, RS ;
Dorian, P ;
Roy, D ;
Sheldon, RS ;
Mitchell, LB ;
Green, MS ;
Klein, GJ ;
O'Brien, B .
CIRCULATION, 2000, 101 (11) :1297-1302
[4]   CLINICAL PREDICTORS OF IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR SHOCKS (RESULTS OF THE CASCADE TRIAL) [J].
DOLACK, GL ;
GREENE, HL ;
POOLE, JE ;
KUDENCHUK, PJ ;
BARDY, GH ;
COBB, LA ;
GRAHAMRENFROE, EL ;
POWELL, JL ;
GALLOWAY, AC ;
KELLIE, J ;
FELLOWS, CL ;
MAIN, CL ;
MCMAHONBUSCH, M ;
BROUDY, DR ;
SANDERS, J ;
GARNI, JE ;
GERITY, D ;
MAYNARD, C ;
HALLSTROM, AP ;
MCBRIDE, R .
AMERICAN JOURNAL OF CARDIOLOGY, 1994, 73 (04) :237-241
[5]   Combination ICD and drug treatments - best options [J].
Dorian, P .
RESUSCITATION, 2000, 45 (03) :S3-S6
[6]   Comparison of the long-term efficacy of implantable defibrillators and sotalol for documented spontaneous sustained ventricular tachyarrhythmias secondary to coronary artery disease [J].
Kovoor, P ;
Yung, A ;
Byth, K ;
Eipper, VE ;
Uther, JB ;
Cooper, MJ ;
Ross, DL .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1999, 29 (03) :331-341
[7]   Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest -: The Cardiac Arrest Study Hamburg (CASH) [J].
Kuck, KH ;
Cappato, R ;
Siebels, J ;
Rüppel, R .
CIRCULATION, 2000, 102 (07) :748-754
[8]   Suppression of sustained ventricular tachyarrhythmias:: A comparison of d,l-sotalol with no antiarrhythmic drug treatment [J].
Kühlkamp, V ;
Mewis, C ;
Mermi, J ;
Bosch, RF ;
Seipel, L .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 33 (01) :46-52
[9]   Efficacy and proarrhythmia with the use of d,l-sotalol for sustained ventricular tachyarrhythmias [J].
Kuhlkamp, V ;
Mermi, J ;
Mewis, C ;
Seipel, L .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1997, 29 (03) :373-381